ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Impact of Positively Charged Backbone Modifications on the Properties of Spherical Nucleic Acids.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Spherical nucleic acids (SNAs) are nanostructures consisting of densely packed, radially oriented oligonucleotides arranged on nanoparticle cores. They are highly relevant to nanomedicine due to their unique physicochemical and biological properties, including efficient uptake across a broad range of cell types (over 50). This uptake is mediated in part by interactions between the oligonucleotide shell and scavenger receptors, making the DNA charge and sequence critical factors governing cellular internalization pathways. Recent advances in deoxynucleic guanidines (DNGs), nucleic acid analogues featuring positively charged guanidinium backbones, provide an opportunity to systematically probe how DNA charge influences SNA uptake. In this work, we report the synthesis of SNAs incorporating DNG-DNA chimeras and evaluate how DNG incorporation alters SNA properties and cellular internalization. We find that cellular uptake increases with the number of DNG inserts, but only when these modifications are displayed on the outer surface of the SNA architecture. Furthermore, receptor blocking experiments indicate that uptake depends not only on scavenger receptor interactions but also on broader cell membrane composition. These findings demonstrate that both structural design and chemical composition can be tuned to control SNA uptake, underscoring the promise of structural nanomedicine for directing SNA-cell interactions and rationally designing next-generation nanotherapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.